WO1995027197A1 - System for ph-neutral longlife precast electrophoresis gel - Google Patents
System for ph-neutral longlife precast electrophoresis gel Download PDFInfo
- Publication number
- WO1995027197A1 WO1995027197A1 PCT/US1995/003647 US9503647W WO9527197A1 WO 1995027197 A1 WO1995027197 A1 WO 1995027197A1 US 9503647 W US9503647 W US 9503647W WO 9527197 A1 WO9527197 A1 WO 9527197A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gel
- tris
- buffer
- buffer solution
- electrophoresis
- Prior art date
Links
- 238000001962 electrophoresis Methods 0.000 title claims description 16
- 239000007853 buffer solution Substances 0.000 claims abstract description 22
- 238000001502 gel electrophoresis Methods 0.000 claims abstract description 8
- 239000000872 buffer Substances 0.000 claims description 30
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical group OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 claims description 24
- 239000007983 Tris buffer Substances 0.000 claims description 19
- 229920002401 polyacrylamide Polymers 0.000 claims description 16
- 239000007987 MES buffer Substances 0.000 claims description 10
- 239000007993 MOPS buffer Substances 0.000 claims description 10
- 150000003573 thiols Chemical class 0.000 claims description 10
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims description 7
- 150000001412 amines Chemical class 0.000 claims description 7
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 4
- RZQXOGQSPBYUKH-UHFFFAOYSA-N 3-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound OCC(CO)(CO)NCC(O)CS(O)(=O)=O RZQXOGQSPBYUKH-UHFFFAOYSA-N 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- NUFBIAUZAMHTSP-UHFFFAOYSA-N 3-(n-morpholino)-2-hydroxypropanesulfonic acid Chemical compound OS(=O)(=O)CC(O)CN1CCOCC1 NUFBIAUZAMHTSP-UHFFFAOYSA-N 0.000 claims description 3
- 239000007991 ACES buffer Substances 0.000 claims description 3
- 108700016232 Arg(2)-Sar(4)- dermorphin (1-4) Proteins 0.000 claims description 3
- 239000007995 HEPES buffer Substances 0.000 claims description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 6
- DBXNUXBLKRLWFA-UHFFFAOYSA-N N-(2-acetamido)-2-aminoethanesulfonic acid Chemical compound NC(=O)CNCCS(O)(=O)=O DBXNUXBLKRLWFA-UHFFFAOYSA-N 0.000 claims 2
- JOCBASBOOFNAJA-UHFFFAOYSA-N N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid Chemical compound OCC(CO)(CO)NCCS(O)(=O)=O JOCBASBOOFNAJA-UHFFFAOYSA-N 0.000 claims 2
- 150000007530 organic bases Chemical class 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 abstract description 41
- 108090000623 proteins and genes Proteins 0.000 abstract description 41
- 230000007935 neutral effect Effects 0.000 abstract description 18
- 238000000926 separation method Methods 0.000 abstract description 17
- 239000000499 gel Substances 0.000 description 103
- 235000018102 proteins Nutrition 0.000 description 38
- 229920002521 macromolecule Polymers 0.000 description 23
- 239000011148 porous material Substances 0.000 description 15
- 239000012146 running buffer Substances 0.000 description 14
- 239000003638 chemical reducing agent Substances 0.000 description 13
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical group NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 11
- 230000003647 oxidation Effects 0.000 description 10
- 238000007254 oxidation reaction Methods 0.000 description 10
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 9
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 9
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 8
- 230000007062 hydrolysis Effects 0.000 description 8
- 238000006460 hydrolysis reaction Methods 0.000 description 8
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 8
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 7
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 7
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 239000004971 Cross linker Substances 0.000 description 5
- 235000018417 cysteine Nutrition 0.000 description 5
- 230000005012 migration Effects 0.000 description 5
- 238000013508 migration Methods 0.000 description 5
- 230000037230 mobility Effects 0.000 description 5
- 125000003396 thiol group Chemical group [H]S* 0.000 description 5
- 102000003846 Carbonic anhydrases Human genes 0.000 description 4
- 108090000209 Carbonic anhydrases Proteins 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 4
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 4
- 108010058846 Ovalbumin Proteins 0.000 description 4
- 101710162629 Trypsin inhibitor Proteins 0.000 description 4
- 229940122618 Trypsin inhibitor Drugs 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 229940092253 ovalbumin Drugs 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- 239000002753 trypsin inhibitor Substances 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 150000001945 cysteines Chemical class 0.000 description 3
- 150000002019 disulfides Chemical class 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 239000012723 sample buffer Substances 0.000 description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 3
- AJTVSSFTXWNIRG-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanesulfonic acid Chemical compound OCC[NH+](CCO)CCS([O-])(=O)=O AJTVSSFTXWNIRG-UHFFFAOYSA-N 0.000 description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 2
- 239000007997 Tricine buffer Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 1
- WQPMYSHJKXVTME-UHFFFAOYSA-N 3-hydroxypropane-1-sulfonic acid Chemical compound OCCCS(O)(=O)=O WQPMYSHJKXVTME-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- -1 cysteine amino acids Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44747—Composition of gel or of carrier mixture
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Physics & Mathematics (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
SYSTEM FOR PH-NEUTRAL LONGLIFE PRECAST ELECTROPHORESIS GEL This invention relates to techniques for gel electrophoresis. More particularly this invention relates to a novel system for gel electrophoresis at approximately neutral pH. Background Of the Invention Gel electrophoresis is a common procedure for the separation of biological molecules, such as DNA, RNA, polypeptides and proteins. In gel electrophoresis, the molecules are separated into bands according to the rate at which an imposed electric field causes them to migrate through a filtering gel. The basic apparatus used in this technique consists of a gel enclosed in a glass tube or sandwiched as a slab between glass or plastic plates. The gel has an open molecular network structure, defining pores which are saturated with an electrically conductive buffered solution-of a salt. These pores through the gel are large enough to admit passage of the migrating macromolecules. The gel is placed in a chamber in contact with buffer solutions which make electrical contact between the gel and the cathode or anode of an electrical power supply. A sample containing the macromolecules and a tracking dye is placed on top of the gel. An electric potential is applied to the gel causing the sample macromolecules and tracking dye to migrate toward the bottom of the gel. The electrophoresis is halted just before the tracking dye reaches the end of the gel. The locations of the bands of separated macromolecules are then determined. By comparing the distance moved by particular bands in comparison to the tracking dye and macromolecules of known mobility, the mobility of other macromolecules can be determined. The size of the macromolecule can then be calculated. The rate of migration of macromolecules through the gel depends upon three principle factors: the porosity of the gel; the size and shape of the macromolecule; and the charge density of the macromolecule. It is critical to an effective electrophoresis system that these three factors be precisely controlled and reproducible from gel to gel and from sample to sample. However, maintaining uniformity between gels is difficult because each of these factors is sensitive to many variables in the chemistry of the gel system. Polyacrylamide gels are commonly used for electrophoresis. Polyacrylamide gel electrophoresis or PAGE is popular because the gels are optically transparent, electrically neutral and can be made with a range of pore sizes. The porosity of a polyacrylamide gel is in part defined by the total percentage of acrylamide monomer plus crosslinker monomer ("%T") it contains. The greater the concentration, the less space there is between strands of the polyacrylamide matrix and hence the smaller the pores through the gel. An 8% polyacrylamide gel has larger pores than a 12% polyacrylamide gel. An 8% polyacrylamide gel consequently permits faster migration of macromolecules with a given shape, size and charge density. When smaller macromolecules are to be separated, it is generally preferable to use a gel with a smaller pore size such as a 20% gel. Conversely for separation of larger macromolecules, a gel with a larger pore size is often used, such as an 8% gel. Pore size is also dependent upon the amount of crosslinker used to polymerize the gel. At any given total monomer concentration, the minimum pore size for a polyacrylamide gel is obtained when the ratio of total monomer to crosslinker is about 20:1, (the usual expression for this ratio would be "5%C"). Several factors may cause undesirable variation in the pore size of gels. Pore size can be increased by incomplete gel polymerization during manufacture. Hydrolysis of the polyacrylamide after polymerization can create fixed negative charges and break down the crosslinks in the gel, which will degrade the separation and increase the pore size. An ideal gel system should have a reproducible pore size and no fixed charge (or at least a constant amount) and should be resistant to change in chemical characteristics or the pore size due to hydrolysis. The size of the macromolecule varies between different macromolecules; the smaller and more compact the macromolecule the easier it will be for the macromolecule to move through the pores of a given gel. Given a constant charge density, the rate of migration of a macromolecule is inversely proportional to the logarithm of its size. For accurate and reproducible electrophoresis, a given type of macromolecule should preferably take on a single form in the gel. One difficulty with maintaining uniformity of the shape of proteins during gel electrophoreses is that disulfide bonds can be formed by oxidation of pairs of cysteine amino acids. Different oxidized forms of the protein then have different shapes and, therefore, migrate through the gel run with slightly different mobilities (usually faster than a completely reduced protein, since the maximum stokes radius and minimum mobility should occur with a completely unfolded form). A heterogeneous mixture of forms leads to apparent band broadening. In order to prevent the formation of disulfide bonds, a reducing agent such as dithiothreitol (DTT) is usually added to the samples to be run. The charge density of the migrating molecule is the third factor affecting its rate of migration through the gel -- the higher the charge density, the more force will be imposed by the electric field upon the macromolecule and the faster the migration rate subject to the limits of size and shape. In SDS-PAGE electrophoresis the charge density of the macromolecules is controlled by adding sodium dodecyl sulfate ("SDS") to the system. SDS molecules associate with the macromolecules and impart a uniform charge density to them substantially negating the effects of any innate molecular charge. SDS PAGE gels are usually poured and run at basic pH. The most common PAGE buffer system employed for the separation of proteins is that developed by Ornstein (1) and modified for use with SDS by Laemmli (2). Laemmli, U.K. (1970) Nature 227, 680-686. The Laemmli buffer system consists of 0.375 M Tris (tris (hydroxy methyl) amino-methane), titrated to pH 8.8. with HC1, in the separating gel. The stacking gel consists of 0.125 M Tris, titrated to pH 6.8. The anode and cathode running buffers contain 0.024 M Tris, 0.192 M glycine, 0.1% SDS. An alternative buffer system is disclosed by Schaegger and von Jagow. Schagger, H. and von Jagow, G., Anal. Biochem. 1987, 166, 368-379. The stacking gel contains 0.75 M Tris, titrated to pH 8.45 with HC1. The separating gel contains 0.9 M Tris, titrated to pH 8.45 with HC1. The cathode buffer contains 0.1 M Tris, 0.1M Tricine, 0.1% SDS. The anode buffer contains 0.2 M Tris, titrated to pH 8.9 with HC1. For both of these systems Tris is the "common ion" which is present in the gel and in the anode and cathode buffers. In the Laemmli system, the pH of the trailing phase in the stacking gel is about 8.9. In the separating gel, the trailing phase pH is about 9.7. At this pH, primary amino groups of proteins react readily with unpolymerized acrylamide, thiol groups are more subject to oxidation to disulf ides, or reaction with unpolymerized polyacrylamide, than at neutral pH and acrylamide itself is subject to hydrolysis. The need for uniformity and predictability is magnified in precast electrophoresis gels which are manufactured by an outside vendor and then shipped to the laboratory where the electrophoresis will be performed. Precast gels must control the properties discussed above and they must be able to maintain this control throughout shipping and storage. The shelf life of many precast gels is limited by the potential for hydrolysis of acrylamide during storage at the high pH of the gel buffer. It is a disadvantage of a high pH gel that the polyacrylamide gel is subject to degradation by hydrolysis and has a limited shelf-life. It is a further disadvantage of a high pH gel that proteins react readily with unpolymerized acrylamide which may interfere with subsequent analysis of the protein such as peptide sequencing. It is a still further disadvantage of a high pH gel that thiol groups are subject to oxidation to disulf ides causing a decreased resolution of separated macromolecules. Summarv of the Invention It is an object of this invention to produce a neutral gel system that reduces protein reaction with unpolymerized acrylamide thereby enhancing yield and resolution. It is a further object of this invention to produce a neutral gel system that prevents formation of disulf ides from free thiol groups thereby enhancing yield and resolution. It is a still further object of this invention to produce a neutral gel system that reduces degradation of the polyacrylamide gel by hydrolysis thereby increasing the useful shelf-life of a precast gel. In accordance with this invention, applicants describe a gel and buffer system wherein separation occurs at neutral pH and proteins remain completely reduced. The above and other objects and advantages of the present invention will be apparent upon consideration of the following detailed description. Detailed Description Of The-Invention Applicants describe a gel and buffer system wherein separation occurs at neutral pH and proteins remain completely reduced. Advantageously, at this neutral pH, primary amino groups of proteins react less readily with unpolymerized acrylamide because protonation of protein amino groups greatly reduces their reactivity to acrylamide or other related blocking agents. Furthermore, at this neutral pH, thiol groups are less subject to oxidation than at higher pH and polyacrylamide itself is less subject to hydrolysis. The result is a gel system with improved stability of the gel matrix and stock solutions. Gels prepared according to this system can be stored under refrigeration for over a year without loss of performance due to acrylamide hydrolysis. Also, stock buffers without reducing agents and stock gel solutions without polymerization initiator can be stored for at least several weeks at room temperature with no loss of performance. An additional benefit is that a single gel recipe, using the same buffer for the stacking and separating gels, can be used with two different running buffers to give two separation systems. Using this feature, an 8% gel, for example, can cover a protein separation range of 2 to 200 kDa. In one embodiment of this invention a polyacrylamide gel of between about 3% and about 25% (%T) acrylamide is polymerized using from about 1% to about 6% crosslinker (%C) using a gel buffer comprising a primary organic amine or substituted amine with a pK near neutrality, titrated with approximately half as much HC1 (on a molar basis), so that the pH of the buffer is approximately neutral. In a preferred embodiment the gel is polymerized using from about 2% to about 5% crosslinker (%C) using a gel buffer comprising Bis-Tris [Bis-(2-hydroxyethyl) iminotris (hydroxymethyl) methane] titrated with HC1. Different separation characteristics can be obtained by running the gel with either a MOPS (3-[N-Morpholino] propanesulfonic acid) or MES (2-(N-Morpholino) ethanesulfonic acid), buffer. 2mM to 10 mM TGA or 2mM to 10mM sodium bisulfite is added to the running buffer to maintain a reducing environment in the gel during electrophoresis. This and other embodiments can be understood by reference to the following illustrative and comparative examples. Examples Bis-Tris, MES, and MOPS were purchased from Sigma (St. Louis, MO) or Research Organics (Cleveland, Ohio). Thiogycollic acid (TGA), DTT and mercaptoethanol (BME) were from Sigma. All other chemicals were reagent, "ultra pure" or "electrophoresis grade" from standard sources. Gels were cast in 1 mm thickness mini-gel cassettes from Novex (San Diego CA) and run in a Novex minicell. The Bis-Tris separating gel and stacking gels were prepared from a 30%T/2.5%C acrylamide/BIS stock solution and a 7X Bis-Tris stock solution (2.5M Bis Tris, 1.5M HC1, pH 6.5). To prepare the separating gel, the stock solutions were blended with ultra pure water to a final concentration 8%T, 0.357M Bis-Tris, to which was added 0.2 ul/ml temed. After degassing, 2.Oul/ml of a 10% solution of APS was added, the gel was immediately poured into the cassette then overlaid with water. Polymerization was allowed to proceed for at least 30 minutes at RT! the water was removed and a 4% stacking gel applied. The stacking gel was prepared in the same fashion as the separating gel, except that the final concentration obtained was 4%T, temed concentration was increased to 0.4ul/ml and the APS increased to 5.Oultml. MOPS running buffer consisted of 50mM MOPS, 50mM Bis-Tris (or TRIS), 0.1% SDS, lmM EDTA. MES running buffer consisted of 50mM MES, 50mM Bis-Tris (or TRIS), 0.1% SDS, lmM EDTA. Sample buffer (2X) consisted of 0.25M Bis-Tris, 0.15M HC1, 10% (w/v) Glycerol, 2% SDS, lmM EDTA, 0.03% Serva Blue G, and 200mM DTT. Samples containing a set of protein standards were heated for 15 min at 70 degrees before application. Bovine serum albumin (BSA), chicken egg ovalbumin, alkylated insulin A and B chain, soybean trypsin inhibitor, and bovine erythrocyte carbonic anhydrase were included in the standard. Sample volume was 5ul in all cases. Example 1 The protein standards were separated on an 8% Bis-Tris gel with MOPS running buffer in the absence of a reducing agent. The resulting separation pattern was very similar to that obtained on an 8% TRIS/glycine gel (Laemmli), with proteins 20,000 and smaller remaining in the stack along with the tracking dye. The BSA band was somewhat diffuse and shifted toward the anode. The Ovalbumin band was also somewhat diffuse. Example 2 The protein standards were separated on an 8% Bis-Tris gel with MOPS running buffer in the presence of TGA in the cathode buffer. Again, the separation pattern was very similar to that obtained on an 8% TRIS/glycine (Laemmli) gel, with proteins 20,000 and smaller remaining in the stack along with the tracking dye. The presence of the reducing agent, 5mM TGA, in the cathode buffer provided for better resolution of the proteins BSA and Ovalbumin compared to the gel run without TGA. Example 3 The protein standards were separated on an 8% Bis-Tris gel with MOPS running buffer in the presence of sodium bisulfite in the cathode buffer. Again, the separation pattern was very similar to that obtained on an 8% TRIS/glycine (Laemmli) gel, with proteins 20,000 and smaller remaining in the stack along with the tracking dye. The presence of the reducing agent, 5mM sodium bisulfite, in the cathode buffer provided for better resolution of the proteins BSA and Ovalbumin compared to the gel run without sodium bisulfite. ExamPle 4 The protein standards were spearated on an 8% Bis-Tris gel with MES running buffer in the absence of a reducing agent. The protein separation was very similar to that obtained from a 12% TRIS/tricine (Schaegger) gel. All proteins were resolved from the stack including insulin A and B chain (3500 and 2500 daltons, respectively). When the gel is run without TGA, soybean trypsin inhibitor had a more prominent doublet. Example 5 The protein standards were separated on an 8% Bis-Tris/Cl gel with Bis-Tris/MES running buffer in the presence of TGA in the cathode buffer. Again, all proteins were resolved from the stack including insulin A and B chain (3500 and 2500 daltons, respectively). The presence of the reducing agent, 5mM TGA, in the cathode buffer provided for better resolution of the protein soybean trypsin inhibitor. Carbonic anhydrase ran as a tight, sharp band under all conditions tested. ExamDle 6 The protein standards were separated on an 8% Bis-Tris/Cl gel with Bis-Tris/MES running buffer in the presence of sodium bisulfite in the cathode buffer. Again, all proteins were resolved from the stack including insulin A and B chain (3500 and 2500 daltons, respectively). The presence of the reducing agent, 5mM sodium bisulfite, in the cathode buffer provided for better. resolution of the protein soybean trypsin inhibitor. Carbonic anhydrase ran as a tight, sharp band under all conditions tested. Although MES and MOPS were selected as desirable running buffers because the resulting system has separation characteristics similar to the commonly used Laemmli and Schaegger gel systems, it was found that a range of buffers are suitable for use in this system. Among the additional buffers giving good results were ACES ([N- (2-Acetomido) ] -2- aminoethanesulfonic acid, MOPSO (2-[N-Morpholino) -2- hydroxypropanesulfonic acid, TES (N-Tris (hydroxymethyl) -2-ethanesulfonic acid, BES (N,N-BIS (Hydroxyethyl) -2-aminoethanesulfonic acid, HEPES (N-2 Hydroxyethyl-piperazine-n-2-ethanesulfonic acid), TAPSO (3-(N-tris-(Hydroxymethyl) methylamino)-2hydroxypropanesulfonic acid. All the proteins that exhibit some band broadening and/or mobility shifts when run in the absence of TGA or sodium bisulfite, have in common a composition that includes multiple cysteines (BSA, for instance, has 35 cysteines). On the other hand carbonic anhydrase, which always runs cleanly, has no cysteines. Moreover, if the reduced proteins are alkylated before running, they run as sharp homogeneous bands even in the absence of a reducing agent. Cysteine-containing proteins appear to give generally sharper bands in the Laemmli system than the neutral system, when both are run with 100mM mercaptoethanol or DTT in the sample buffer but without TGA in the running buffer. Since thiol oxidation is more favored as the pH increases, it would be expected that the higher pH of the Laemmli system would cause oxidation of disulfide to be at least as pronounced as it is in the neutral pH system. However, DTT and similar "neutral" thiol reducing agents are weak acids (with pKa's around pH 8-9). Thus, at basic pH, these reducing agents migrate into the gel and, if present at sufficient concentration, provide some protection against oxidation of sulfhydryls. At a neutral separating pH, DTT from the sample buffer is in an uncharged form and will remain behind in the sample well. Thus, no reducing agent migrates into the gel. To maintain proteins in a reduced form during electrophoresis at neutral pH, it was found advantageous to use a reducing agent that would migrate into the gel at neutral pH. Sodium Bisulfite (2-10mM) was found to maintain a reducing environment in the gel during electrophoresis. Fully reduced TGA (or similar negatively charged thiols) give similar results at comparable concentrations. However, partially oxidized TGA will promote partial oxidation of protein thiols. Because reduction (oxidation) of protein thiols will take place via disulfide interchange, the ratio of reduced to oxidized thiols in the protein will substantially reflect the ratio of reduced to oxidized thiols in the TGA. Conversely, sulfite oxidizes to sulfate, which does not participate in redox reactions under conditions found in the gel. Therefore, regardless of the sulfite/sulfate ratio in a partially oxidized preparation of sulfite, as long as sufficient sulfite remains, proteins will be protected against thiol oxidation. It was also found that TRIS could be substituted for Bis-Tris in the running buffer with no visible effect on the separation quality. Bis-Tris may be preferred where the protein will be intentionally modified post-separation. Bis-Tris is a tertiary amine and will not interfere with the protein modifying agents which react through primary amines. TRIS, however is the preferred choice for routine use, because it is available at significantly lower cost than Bis-Tris. While the invention has been explained in relation to its preferred embodiments, it is to be understood that various modifications thereof will become apparent to those skilled in the art. The foregoing disclosure is not intended or to be construed to limit the present invention, or to otherwise exclude any such other embodiments, adaptions, variations and equivalent arrangements, the present invention being limited only by the claims appended hereto and the equivalents thereof.
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP52575995A JP3679117B2 (en) | 1994-03-31 | 1995-03-29 | System for neutral pH long-life precast electrophoresis gels |
EP95914833A EP0753142B1 (en) | 1994-03-31 | 1995-03-29 | System for gel electrophoresis |
DE69511389T DE69511389T2 (en) | 1994-03-31 | 1995-03-29 | System for gel electrophoresis |
CA002186120A CA2186120C (en) | 1994-03-31 | 1995-03-29 | System for ph-neutral longlife precast electrophoresis gel |
AU21926/95A AU698145B2 (en) | 1994-03-31 | 1995-03-29 | System for PH-neutral longlife precast electrophoresis gel |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/221,939 US5578180A (en) | 1994-03-31 | 1994-03-31 | System for PH-neutral longlife precast electrophoresis gel |
US08/221,939 | 1994-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995027197A1 true WO1995027197A1 (en) | 1995-10-12 |
Family
ID=22830063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1995/003647 WO1995027197A1 (en) | 1994-03-31 | 1995-03-29 | System for ph-neutral longlife precast electrophoresis gel |
Country Status (8)
Country | Link |
---|---|
US (5) | US5578180A (en) |
EP (1) | EP0753142B1 (en) |
JP (4) | JP3679117B2 (en) |
KR (1) | KR100368955B1 (en) |
AU (1) | AU698145B2 (en) |
CA (1) | CA2186120C (en) |
DE (1) | DE69511389T2 (en) |
WO (1) | WO1995027197A1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6783651B1 (en) | 1994-03-31 | 2004-08-31 | Invitrogen Corporation | System for pH-neutral stable electrophoresis gel |
US7282128B2 (en) | 2001-07-19 | 2007-10-16 | Applera Corporation | Buffers for electrophoresis and use thereof |
US7781173B2 (en) | 2003-09-25 | 2010-08-24 | Life Technologies Corporation | Homogeneous populations of molecules |
US8012715B2 (en) | 1997-01-08 | 2011-09-06 | Life Technologies Corporation | Methods for production of proteins |
US9164099B2 (en) | 2002-09-12 | 2015-10-20 | Life Technologies Corporation | Site-specific labeling of affinity tags in fusion proteins |
US9470655B2 (en) | 2013-03-15 | 2016-10-18 | Bio-Rad Laboratories, Inc. | Polyacrylamide gels for rapid casting, blotting, and imaging, with storage stability |
US9486741B2 (en) | 2008-09-02 | 2016-11-08 | Bio-Rad Laboratories, Inc. | Hydrolysis-resistant polyacrylamide gels |
US9733212B2 (en) | 2006-07-21 | 2017-08-15 | Life Technologies Corporation | Sharply resolving labeled protein molecular weight standards |
US11105769B2 (en) | 2009-08-24 | 2021-08-31 | Life Technologies Corporation | System for rapid high-resolution gel electrophoresis |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5578180A (en) * | 1994-03-31 | 1996-11-26 | Novel Experimental Technology | System for PH-neutral longlife precast electrophoresis gel |
US6143154A (en) * | 1994-03-31 | 2000-11-07 | Novex | System for PH-neutral stable electrophoresis gel |
SE9404141D0 (en) * | 1994-11-30 | 1994-11-30 | Pharmacia Biotech Ab | New buffer system for electrophoresis |
US7824532B2 (en) * | 1995-04-26 | 2010-11-02 | Life Technologies Corporation | Apparatus and method for electrophoresis |
US6464850B1 (en) | 1998-07-31 | 2002-10-15 | Biowhittaker Molecular Applications, Inc. | Method for producing hydrophilic monomers and uses thereof |
US6758953B2 (en) | 1999-10-28 | 2004-07-06 | Nathan A. Thomas | Multistage electrophoresis apparatus and method of use for the separation and purification of cells, particles and solutes |
CN1247990C (en) | 1999-12-02 | 2006-03-29 | 海茂株式会社 | Polyacrylamide precast gels for electrophoresis, process for producing the same and electrophoresis method by using the gels |
JP3942001B2 (en) * | 1999-12-02 | 2007-07-11 | ハイモ株式会社 | Polyacrylamide precast gel for electrophoresis, method for producing the same, and method for separating and analyzing proteins |
AU759336B2 (en) * | 2000-02-18 | 2003-04-10 | Dycent Biotech (Shanghai) Co., Limited | Improved electrophoresis gels |
AUPQ571400A0 (en) | 2000-02-18 | 2000-03-16 | Life Therapeutics Limited | Improved electrophoresis gels |
US20040014082A1 (en) * | 2000-08-11 | 2004-01-22 | Invitrogen Corporation | Highly homogeneous molecular markers for electrophoresis |
US6562213B1 (en) | 2000-08-30 | 2003-05-13 | Ethrog Biotechnology Ltd. | Electrophoresis apparatus for simultaneous loading of multiple samples |
WO2002071024A2 (en) * | 2001-03-08 | 2002-09-12 | Ethrog Biotechnology Ltd. | Apparatus and method for electrophoresis |
SE0201655D0 (en) * | 2002-05-31 | 2002-05-31 | Amersham Biosciences Ab | A method of electrophoresis |
US7850835B2 (en) * | 2003-05-09 | 2010-12-14 | Life Technologies Corporation | Solution phase electrophoresis device, components, and methods |
US7622028B2 (en) * | 2003-05-09 | 2009-11-24 | Life Technologies Corporation | Solution phase electrophoresis device, components, and methods |
US20050121325A1 (en) * | 2003-09-19 | 2005-06-09 | Timothy Updyke | Composite compositions for electrophoresis |
WO2005031332A1 (en) * | 2003-09-22 | 2005-04-07 | Invitrogen Corporation | Apparatus for concurrent electrophoresis in a plurality of gels |
WO2005036153A1 (en) * | 2003-10-07 | 2005-04-21 | Invitrogen Corporation | Improved isoelectric focusing gels and methods of use thereof |
US20060118418A1 (en) * | 2004-12-02 | 2006-06-08 | Mathoor Sivaram | Electrophoresis gels and buffers and methods of performing electrophoresis |
US8173002B2 (en) * | 2005-02-24 | 2012-05-08 | Life Technologies Corporation | Electro-blotting devices, systems, and kits, and methods for their use |
EP2180316A4 (en) * | 2007-08-17 | 2010-10-20 | Hymo Corp | Precast gel for electrophoresis, method for production thereof, and use thereof |
JP4838358B2 (en) * | 2007-08-17 | 2011-12-14 | ハイモ株式会社 | Precast gel for electrophoresis, method for producing the same, and method for using the same |
WO2010006318A2 (en) * | 2008-07-11 | 2010-01-14 | Life Technologies Corporation | Electrophoretically enhanced detection of analytes on a solid support |
US8945360B2 (en) * | 2009-01-27 | 2015-02-03 | Bio-Rad Laboratories, Inc. | High-performing electrophoresis gels with extended shelf lives |
WO2011134072A1 (en) | 2010-04-27 | 2011-11-03 | Dgel Electrosystem Inc. | Electrophoresis buffer for faster migration, improved resolution and extended shelf-life |
US9250208B2 (en) | 2011-07-14 | 2016-02-02 | Dgel Electrosystem Inc. | Electrophoresis buffer for extending the useful electrophoresis life of an electrophoresis gel |
US9291596B2 (en) | 2013-02-12 | 2016-03-22 | Pierce Biotechnology, Inc. | Electroblot transfer buffer |
USD738527S1 (en) | 2013-05-28 | 2015-09-08 | Life Technologies Corporation | Electroblotting apparatus |
US10208332B2 (en) | 2014-05-21 | 2019-02-19 | Integenx Inc. | Fluidic cartridge with valve mechanism |
EP3209410A4 (en) | 2014-10-22 | 2018-05-02 | IntegenX Inc. | Systems and methods for sample preparation, processing and analysis |
WO2018156880A1 (en) * | 2017-02-24 | 2018-08-30 | Life Technologies Corporation | Capillary electrophoresis systems, related devices, and related methods |
CN112305048B (en) * | 2020-12-22 | 2021-03-30 | 苏桥生物(苏州)有限公司 | Application of MES and SDS buffer solution in reduction of fragment peaks of capillary electrophoresis |
CN113325055A (en) * | 2021-04-22 | 2021-08-31 | 中国人民解放军空军军医大学 | Polyacrylamide gel electrophoresis buffer system and application thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3948743A (en) * | 1975-04-14 | 1976-04-06 | Bio-Rad Laboratories | Method for gel electrophoresis |
US4209373A (en) * | 1979-06-01 | 1980-06-24 | Corning Glass Works | Acidic agar gel electrochromatography of hemoglobins |
US4481094A (en) * | 1982-05-17 | 1984-11-06 | Techamerica Group, Inc. | Stabilized polyacrylamide gels and system for SDS electrophoresis |
EP0518475A1 (en) * | 1991-05-31 | 1992-12-16 | Beckman Instruments, Inc. | Analysis of samples utilizing capillary electrophoresis |
EP0566784A1 (en) * | 1990-11-19 | 1993-10-27 | Hymo Corporation | Polyacrylamide gel for electrophoresis |
US5275708A (en) * | 1992-03-20 | 1994-01-04 | Thomas Jefferson University | Cetyltrimethylammonium bromide gel electrophoresis |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3870812A (en) * | 1970-04-02 | 1975-03-11 | Gen Foods Corp | Protein gel modification |
US4139440A (en) * | 1977-06-20 | 1979-02-13 | Government Of The United States | Electrofocusing in buffers |
US4542200A (en) * | 1982-02-19 | 1985-09-17 | Fmc Corporation | Polyacrylamide cross-linked with a polysaccharide resin as electrophoretic gel medium |
CA1206666A (en) * | 1982-02-19 | 1986-06-24 | Samuel Nochumson | Copolymer of acrylamide and polysaccharide resin as electrophoretic gel medium |
US4504641A (en) * | 1982-02-19 | 1985-03-12 | Fmc Corporation | Polyacrylamide cross-linked with a polysaccharide resin as electrophoretic gel medium |
JPS59212751A (en) * | 1983-05-19 | 1984-12-01 | Fuji Photo Film Co Ltd | Medium material for electrophoresis |
US4950708A (en) * | 1988-08-29 | 1990-08-21 | Bio-Rad Laboratories, Inc. | Stable polyacrylamide gels containing chaotropic agents |
WO1992004625A1 (en) * | 1990-08-29 | 1992-03-19 | Budin Michov | Protein separation by sds electrophoresis in a homogenous gel using a tris-formiate-taurinate buffer system and suitable homogenous electrophoresis plates therefor |
JP3071926B2 (en) * | 1992-01-28 | 2000-07-31 | 第一化学薬品株式会社 | Method for producing polyacrylamide gel plate for electrophoresis |
US5213669A (en) * | 1992-01-31 | 1993-05-25 | Beckman Instruments, Inc. | Capillary column containing a dynamically cross-linked composition and method of use |
AU6525094A (en) * | 1993-03-26 | 1994-10-24 | United States Biochemical Corporation | Improved sequencing gel |
US5578180A (en) * | 1994-03-31 | 1996-11-26 | Novel Experimental Technology | System for PH-neutral longlife precast electrophoresis gel |
-
1994
- 1994-03-31 US US08/221,939 patent/US5578180A/en not_active Expired - Lifetime
-
1995
- 1995-03-29 JP JP52575995A patent/JP3679117B2/en not_active Expired - Lifetime
- 1995-03-29 DE DE69511389T patent/DE69511389T2/en not_active Expired - Lifetime
- 1995-03-29 EP EP95914833A patent/EP0753142B1/en not_active Expired - Lifetime
- 1995-03-29 KR KR1019960705350A patent/KR100368955B1/en not_active IP Right Cessation
- 1995-03-29 CA CA002186120A patent/CA2186120C/en not_active Expired - Lifetime
- 1995-03-29 WO PCT/US1995/003647 patent/WO1995027197A1/en active IP Right Grant
- 1995-03-29 AU AU21926/95A patent/AU698145B2/en not_active Ceased
-
1996
- 1996-10-11 US US08/730,678 patent/US5922185A/en not_active Expired - Lifetime
-
1999
- 1999-01-11 US US09/229,392 patent/US6096182A/en not_active Expired - Lifetime
- 1999-01-11 US US09/228,875 patent/US6162338A/en not_active Expired - Lifetime
- 1999-01-11 US US09/229,388 patent/US6059948A/en not_active Expired - Lifetime
-
2004
- 2004-03-09 JP JP2004066437A patent/JP3934114B2/en not_active Expired - Lifetime
-
2006
- 2006-03-28 JP JP2006089526A patent/JP2006177986A/en not_active Withdrawn
-
2007
- 2007-06-12 JP JP2007154880A patent/JP4055862B2/en not_active Expired - Lifetime
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3948743A (en) * | 1975-04-14 | 1976-04-06 | Bio-Rad Laboratories | Method for gel electrophoresis |
US4209373A (en) * | 1979-06-01 | 1980-06-24 | Corning Glass Works | Acidic agar gel electrochromatography of hemoglobins |
US4481094A (en) * | 1982-05-17 | 1984-11-06 | Techamerica Group, Inc. | Stabilized polyacrylamide gels and system for SDS electrophoresis |
EP0566784A1 (en) * | 1990-11-19 | 1993-10-27 | Hymo Corporation | Polyacrylamide gel for electrophoresis |
EP0518475A1 (en) * | 1991-05-31 | 1992-12-16 | Beckman Instruments, Inc. | Analysis of samples utilizing capillary electrophoresis |
US5275708A (en) * | 1992-03-20 | 1994-01-04 | Thomas Jefferson University | Cetyltrimethylammonium bromide gel electrophoresis |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7892409B2 (en) | 1994-03-31 | 2011-02-22 | Life Technologies Corporation | System for pH-neutral stable electrophoresis gel |
US6783651B1 (en) | 1994-03-31 | 2004-08-31 | Invitrogen Corporation | System for pH-neutral stable electrophoresis gel |
US7422670B2 (en) | 1994-03-31 | 2008-09-09 | Timothy V Updyke | System for pH-neutral stable electrophoresis gel |
US7452453B2 (en) | 1994-03-31 | 2008-11-18 | Invitrogen Corporation | System for pH-neutral stable electrophoresis gel |
US7967966B2 (en) | 1994-03-31 | 2011-06-28 | Life Technologies Corporation | System for pH-neutral stable electrophoresis gel |
US8519099B2 (en) | 1997-01-08 | 2013-08-27 | Life Technologies Corporation | Methods for production of proteins |
US9409942B2 (en) | 1997-01-08 | 2016-08-09 | Life Technologies Corporation | Methods for production of proteins |
US8012715B2 (en) | 1997-01-08 | 2011-09-06 | Life Technologies Corporation | Methods for production of proteins |
US8389681B2 (en) | 1997-01-08 | 2013-03-05 | Life Technologies Corporation | Methods for production of proteins |
US8512537B2 (en) | 2001-07-19 | 2013-08-20 | Applied Biosystems, Llc | Buffers for electrophoresis and use thereof |
US7282128B2 (en) | 2001-07-19 | 2007-10-16 | Applera Corporation | Buffers for electrophoresis and use thereof |
US9164099B2 (en) | 2002-09-12 | 2015-10-20 | Life Technologies Corporation | Site-specific labeling of affinity tags in fusion proteins |
US7781173B2 (en) | 2003-09-25 | 2010-08-24 | Life Technologies Corporation | Homogeneous populations of molecules |
US9523692B2 (en) | 2003-09-25 | 2016-12-20 | Life Technologies Corporation | Homogenous populations of molecules |
US9733212B2 (en) | 2006-07-21 | 2017-08-15 | Life Technologies Corporation | Sharply resolving labeled protein molecular weight standards |
US10302591B2 (en) | 2006-07-21 | 2019-05-28 | Life Technologies Corporation | Sharply resolving labeled protein molecular weight standards |
US9486741B2 (en) | 2008-09-02 | 2016-11-08 | Bio-Rad Laboratories, Inc. | Hydrolysis-resistant polyacrylamide gels |
US10119934B2 (en) | 2008-09-02 | 2018-11-06 | Bio-Rad Laboratories, Inc. | Hydrolysis-resistant polyacrylamide gels |
US11105769B2 (en) | 2009-08-24 | 2021-08-31 | Life Technologies Corporation | System for rapid high-resolution gel electrophoresis |
US9470655B2 (en) | 2013-03-15 | 2016-10-18 | Bio-Rad Laboratories, Inc. | Polyacrylamide gels for rapid casting, blotting, and imaging, with storage stability |
Also Published As
Publication number | Publication date |
---|---|
CA2186120C (en) | 2005-06-21 |
US6096182A (en) | 2000-08-01 |
EP0753142A1 (en) | 1997-01-15 |
JP2004163442A (en) | 2004-06-10 |
US6059948A (en) | 2000-05-09 |
AU2192695A (en) | 1995-10-23 |
JP4055862B2 (en) | 2008-03-05 |
JP3679117B2 (en) | 2005-08-03 |
JP2007263976A (en) | 2007-10-11 |
CA2186120A1 (en) | 1995-10-12 |
KR100368955B1 (en) | 2003-04-11 |
DE69511389T2 (en) | 2000-04-20 |
US6162338A (en) | 2000-12-19 |
JP3934114B2 (en) | 2007-06-20 |
JP2006177986A (en) | 2006-07-06 |
JPH09512907A (en) | 1997-12-22 |
DE69511389D1 (en) | 1999-09-16 |
US5922185A (en) | 1999-07-13 |
EP0753142B1 (en) | 1999-08-11 |
US5578180A (en) | 1996-11-26 |
AU698145B2 (en) | 1998-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU698145B2 (en) | System for PH-neutral longlife precast electrophoresis gel | |
US7967966B2 (en) | System for pH-neutral stable electrophoresis gel | |
US5470916A (en) | Formulations for polyacrylamide matrices in electrokinetic and chromatographic methodologies | |
Goldenberg et al. | Gel electrophoresis in studies of protein conformation and folding | |
US9486741B2 (en) | Hydrolysis-resistant polyacrylamide gels | |
JP5619165B2 (en) | A system for high-speed, high-resolution gel electrophoresis. | |
US3948743A (en) | Method for gel electrophoresis | |
US6143154A (en) | System for PH-neutral stable electrophoresis gel | |
JP3553604B2 (en) | A new buffer system for electrophoresis and its use | |
US20060118418A1 (en) | Electrophoresis gels and buffers and methods of performing electrophoresis | |
US20100213060A1 (en) | Aqueous transfer buffer | |
Jones et al. | A method for the preparation of low-pH dodecyl sulphate/polyacrylamide-gradient gels. | |
AU2007243994B2 (en) | Electrodic bridge | |
EP3362786A1 (en) | Electrophoresis gel with extended shelf life and high performance | |
Westermeier | 5 Slab gel IEF | |
GELFI | PIER GIORGIO RIGHETTI, ALESSANDRA BOSSI, and | |
Posch et al. | Principles and Challenges of Basic Protein Separation by Two-Dimensional (2D) Electrophoresis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NL NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2186120 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019960705350 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1995914833 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1995914833 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 1995914833 Country of ref document: EP |